Regeneus Ltd, a clinical-stage regenerative medicine company, today announced that a preclinical post-operative pain study has shown that topical application of Sygenus, has significantly greater and longer lasting analgesic effect than an injection of morphine. Sygenus is an allogeneic cell ...
Read More »The Cell Factory demonstrates anti-inflammatory mode of action of extracellular vesicle drug candidate for Epilepsy
The Cell Factory, a company of Esperite Group in collaboration with Bambino Gesù Children’s Hospital in Rome, Mario Negri Institute for Pharmacological Research in Milan and Women’s and Children’s Health Department of the University of Padua are developing the EVs ...
Read More »